Clostridioides difficile (previously known as Clostridium difficile ... year,” said Centers for Disease Control and Prevention (CDC) Director Tom Frieden, MD, MPH. Antibiotics are known to ...

Clostridium difficile is a Gram-positive spore-forming bacteria that is a normal component of the colon flora in humans. It can cause antibiotic-associated diarrhea (ADD) when competing bacteria ...

Clostridium difficile infection (CDI) is a significant health concern, particularly in individuals who have recently undergone antibiotic treatment. CDI can lead to severe gastrointestinal issues ...

Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal ...

Video content above is prompted by the following: What are the main unmet needs for recurrent C difficile infections and how do you see the field evolving in the future?

The CDC is expected to release a new list in the fall of 2019 ... Antibiotic treatment alters the intestinal microbiota resulting in hard-to-treat Clostridium difficile infections C. difficile ...

Antimicrobial Resistance Diagnostics market is growing rapidly due to the high prevalence of antimicrobial resistance and the critical need. VANCOUVER, BRI ...

The AHA's Living Learning Network is partnering with the Centers for Disease Control and Prevention to launch the Sepsis Champions Leadership Series. These monthly events aim to improve sepsis care ...

Highlights:New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum ...

In the U.S., the estimated national cost to treat these infections exceeds $4.6 billion annually (CDC Antimicrobial ... primary and recurrent Clostridium difficile disease are a potent antibiotic ...